AAUM (Average Assets Under Management) of ₹3,699.49 Cr for Jul-Sep 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 65.1% | 66.4% | ▲ +1.4% |
| Healthcare Services | 18.0% | 20.4% | ▲ +2.3% |
| Insurance | 1.1% | 1.0% | ● -0.1% |
| Healthcare Equipment & Supplies | 0.2% | 0.1% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 66.4% | 65.0% | ▼ -1.5% |
| Healthcare Services | 20.4% | 17.8% | ▼ -2.5% |
| Insurance | 1.0% | 1.0% | ● +0.0% |
| Healthcare Equipment & Supplies | 0.1% | 0.1% | ● 0.0% |
Comparing Aug 2026 → Sep 2026
| # | Stock | Sector | Weight (Sep 2026) |
|---|---|---|---|
| 1 | Abbott India Limited ₹9.92 Cr |
Pharmaceuticals & Biotechnology | 0.26% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Alkem Laboratories Limited ₹177.96 Cr |
Pharmaceuticals & Biotechnology | 4.08% | 4.75% | +0.67% |
| 2 | Indoco Remedies Ltd ₹84.93 Cr |
Pharmaceuticals & Biotechnology | 2.06% | 2.26% | +0.20% |
| 3 | Gland Pharma Limited ₹230.58 Cr |
Pharmaceuticals & Biotechnology | 5.98% | 6.15% | +0.17% |
| 4 | Aarti Drugs Ltd ₹36.72 Cr |
Pharmaceuticals & Biotechnology | 0.91% | 0.98% | +0.07% |
| 5 | Syngene International Limited ₹50.60 Cr |
Healthcare Services | 1.31% | 1.35% | +0.04% |
| 6 | Alembic Pharmaceuticals Limited ₹119.07 Cr |
Pharmaceuticals & Biotechnology | 3.14% | 3.18% | +0.04% |
| 7 | ICICI Lombard General Insurance Company Limited ₹38.38 Cr |
Insurance | 0.99% | 1.02% | +0.03% |
| 8 | Kovai Medical Center and Hospital Limited ₹106.21 Cr |
Healthcare Services | 2.80% | 2.83% | +0.03% |
| 9 | Divi's Laboratories Limited ₹156.30 Cr |
Pharmaceuticals & Biotechnology | 4.15% | 4.17% | +0.02% |
| # | Stock | Sector | Aug 2026 | Sep 2026 | Change |
|---|---|---|---|---|---|
| 1 | Manipal Health Enterprises Ltd ₹69.42 Cr |
Healthcare Services | 3.70% | 1.85% | -1.85% |
| 2 | Sai Life Sciences Limited ₹244.33 Cr |
Pharmaceuticals & Biotechnology | 7.45% | 6.52% | -0.93% |
| 3 | IPCA Laboratories Limited ₹305.01 Cr |
Pharmaceuticals & Biotechnology | 8.74% | 8.13% | -0.61% |
| 4 | Sun Pharmaceutical Industries Limited ₹278.96 Cr |
Pharmaceuticals & Biotechnology | 7.95% | 7.44% | -0.51% |
| 5 | Pfizer Limited ₹102.16 Cr |
Pharmaceuticals & Biotechnology | 3.22% | 2.72% | -0.50% |
| 6 | Apollo Hospitals Enterprise Limited ₹227.60 Cr |
Healthcare Services | 6.47% | 6.07% | -0.40% |
| 7 | Thyrocare Technologies Limited ₹71.64 Cr |
Healthcare Services | 2.11% | 1.91% | -0.20% |
| 8 | Cipla Limited ₹269.39 Cr |
Pharmaceuticals & Biotechnology | 7.35% | 7.18% | -0.17% |
| 9 | Vijaya Diagnostic Centre Limited ₹88.52 Cr |
Healthcare Services | 2.44% | 2.36% | -0.08% |
| 10 | Concord Biotech Limited ₹101.07 Cr |
Pharmaceuticals & Biotechnology | 2.77% | 2.70% | -0.07% |
27 stocks — Sep 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹305.01 Cr |
Pharmaceuticals & Biotechnology |
8.13%
|
|
| 2 |
₹278.96 Cr |
Pharmaceuticals & Biotechnology |
7.44%
|
|
| 3 |
₹269.39 Cr |
Pharmaceuticals & Biotechnology |
7.18%
|
|
| 4 |
₹244.33 Cr |
Pharmaceuticals & Biotechnology |
6.52%
|
|
| 5 |
₹230.58 Cr |
Pharmaceuticals & Biotechnology |
6.15%
|
|
| 6 |
₹227.60 Cr |
Healthcare Services |
6.07%
|
|
| 7 |
₹177.96 Cr |
Pharmaceuticals & Biotechnology |
4.75%
|
|
| 8 |
₹156.30 Cr |
Pharmaceuticals & Biotechnology |
4.17%
|
|
| 9 |
₹142.21 Cr |
Pharmaceuticals & Biotechnology |
3.79%
|
|
| 10 |
₹119.07 Cr |
Pharmaceuticals & Biotechnology |
3.18%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.